Cargando…
Defining the pathway to timely diagnosis and treatment of interstitial lung disease: a US Delphi survey
INTRODUCTION: Timely diagnosis of interstitial lung disease (ILD) is limited by obstacles in the current patient pathway. Misdiagnosis and delays are common and may lead to a significant burden of diagnostic procedures and worse outcomes. This Delphi survey aimed to identify consensus on the key ste...
Autores principales: | Case, Amy Hajari, Beegle, Scott, Hotchkin, David L, Kaelin, Thomas, Kim, Hyun Joo, Podolanczuk, Anna J, Ramaswamy, Murali, Remolina, Carlos, Salvatore, Mary M, Tu, Conan, de Andrade, Joao A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680004/ https://www.ncbi.nlm.nih.gov/pubmed/38007235 http://dx.doi.org/10.1136/bmjresp-2022-001594 |
Ejemplares similares
-
Clinical use of nintedanib in patients with idiopathic pulmonary fibrosis
por: Hajari Case, Amy, et al.
Publicado: (2017) -
Analytic Morphomics in Myositis-Related Interstitial Lung Disease
por: O’Mahony, Alexander T., et al.
Publicado: (2023) -
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)
por: Wild, Jim M, et al.
Publicado: (2021) -
Feasibility of cardiopulmonary exercise testing in interstitial lung disease: the PETFIB study
por: Tomlinson, Owen, et al.
Publicado: (2021) -
Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases
por: Salonen, Johanna, et al.
Publicado: (2020)